| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1.094,005759 | 18/06/2026 | 3,08% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 1.288,587383 | 18/06/2026 | 3,26% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 797,347526 | 18/06/2026 | 3,26% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 147,587471 | 18/06/2026 | 2,97% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | DEUDA PRIVADA EMERGENTES HRD CCY | 828,828200 | 18/06/2026 | 2,96% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 137,780298 | 18/06/2026 | 2,72% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 117,546462 | 18/06/2026 | 2,92% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | RVI BIOTECNOLOGÍA | 132,410000 | 22/06/2026 | 12,75% | 39,58% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | RVI BIOTECNOLOGÍA | 847,067039 | 22/06/2026 | 12,16% | 35,54% | ** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | RVI BIOTECNOLOGÍA | 383,406075 | 22/06/2026 | 12,70% | 39,76% | *** |
